| Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation ME Figueroa, O Abdel-Wahab, C Lu, PS Ward, J Patel, A Shih, Y Li, ... Cancer cell 18 (6), 553-567, 2010 | 3167 | 2010 |
| Prognostically useful gene-expression profiles in acute myeloid leukemia PJM Valk, RGW Verhaak, MA Beijen, CAJ Erpelinck, ... New England Journal of Medicine 350 (16), 1617-1628, 2004 | 1492 | 2004 |
| DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia ME Figueroa, S Lugthart, Y Li, C Erpelinck-Verschueren, X Deng, ... Cancer cell 17 (1), 13-27, 2010 | 1000 | 2010 |
| A 17-gene stemness score for rapid determination of risk in acute leukaemia SWK Ng, A Mitchell, JA Kennedy, WC Chen, J McLeod, N Ibrahimova, ... Nature 540 (7633), 433-437, 2016 | 835 | 2016 |
| Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression … RGW Verhaak, CS Goudswaard, W Van Putten, MA Bijl, MA Sanders, ... Blood 106 (12), 3747-3754, 2005 | 817 | 2005 |
| Molecular minimal residual disease in acute myeloid leukemia M Jongen-Lavrencic, T Grob, D Hanekamp, FG Kavelaars, A Al Hinai, ... New England Journal of Medicine 378 (13), 1189-1199, 2018 | 813 | 2018 |
| A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia S Gröschel, MA Sanders, R Hoogenboezem, E de Wit, BAM Bouwman, ... Cell 157 (2), 369-381, 2014 | 740 | 2014 |
| Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely … BJ Wouters, B Löwenberg, CAJ Erpelinck-Verschueren, WLJ van Putten, ... Blood, The Journal of the American Society of Hematology 113 (13), 3088-3091, 2009 | 726 | 2009 |
| Barjesteh van Waalwijk van Doorn-Khosrovani S, Boer JM, et al. Prognostically useful gene-expression profiles in acute myeloid leukemia PJ Valk, RG Verhaak, MA Beijen, CA Erpelinck N Engl J Med 350 (16), 1617-28, 2004 | 635* | 2004 |
| High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study M Terwijn, WLJ van Putten, A Kelder, VHJ van der Velden, RA Brooimans, ... Journal of clinical oncology 31 (31), 3889-3897, 2013 | 553 | 2013 |
| MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia M Jongen-Lavrencic, SM Sun, MK Dijkstra, PJM Valk, B Löwenberg Blood, The Journal of the American Society of Hematology 111 (10), 5078-5085, 2008 | 529 | 2008 |
| Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value S Abbas, S Lugthart, FG Kavelaars, A Schelen, JE Koenders, ... Blood, The Journal of the American Society of Hematology 116 (12), 2122-2126, 2010 | 509 | 2010 |
| 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party M Heuser, SD Freeman, GJ Ossenkoppele, F Buccisano, CS Hourigan, ... Blood, The Journal of the American Society of Hematology 138 (26), 2753-2767, 2021 | 462 | 2021 |
| Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further … E Taskesen, L Bullinger, A Corbacioglu, MA Sanders, CAJ Erpelinck, ... Blood, The Journal of the American Society of Hematology 117 (8), 2469-2475, 2011 | 457 | 2011 |
| Incidence and prognosis of c‐KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias RS Care, PJM Valk, AC Goodeve, FM Abu‐Duhier, ... British journal of haematology 121 (5), 775-777, 2003 | 417 | 2003 |
| Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia S Li, FE Garrett-Bakelman, SS Chung, MA Sanders, T Hricik, F Rapaport, ... Nature medicine 22 (7), 792-799, 2016 | 402 | 2016 |
| Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling RGW Verhaak, BJ Wouters, CAJ Erpelinck, S Abbas, HB Beverloo, ... haematologica 94 (1), 131, 2009 | 396 | 2009 |
| Tel/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survival H Hock, E Meade, S Medeiros, JW Schindler, PJM Valk, Y Fujiwara, ... Genes & development 18 (19), 2336-2341, 2004 | 378 | 2004 |
| High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients S Barjesteh van Waalwijk van Doorn-Khosrovani, C Erpelinck, ... Blood, The Journal of the American Society of Hematology 101 (3), 837-845, 2003 | 368* | 2003 |
| NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern IHIM Hollink, MM van den Heuvel-Eibrink, ST Arentsen-Peters, ... Blood, The Journal of the American Society of Hematology 118 (13), 3645-3656, 2011 | 349 | 2011 |
